AnteoTech (ASX:ADO) share price falls on TGA update

The biotech company has delivered an update on its COVID rapid antigen test.

| More on:
medical researcher with mask carries tray of samples

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The AnteoTech Ltd (ASX: ADO) share price is in the red during late afternoon trading. This comes after the company provided an update on its COVID-19 rapid antigen test.

At the time of writing, the biotechnology company's shares were trading for 17 cents apiece, down 2.86% on yesterday's close

Let's take a look at what may be impacting the company's shares today.

What did AnteoTech announce?

AnteoTech informed the market it had heard from the Therapeutic Goods Administration (TGA) on its SARS CoV (COVID-19) rapid antigen test and Eugeni reader platform.

The TGA has asked AnteoTech to review how its diagnostic test will cover COVID-19 variants.

The regulatory body has also requested that AnteoTech update the TGA on how it plans to monitor for new strains of the virus.

The company says it will also need to provide an update on other technical and performance details.

The AnteoTech share price received a shot in the arm in September when the company announced it had submitted its rapid antigen COVID test to the TGA.

Then, the company said its nasal swab test was able to detect COVID-19 in 1 minute in 97.3% of cases. AnteoTech is also working on a saliva-based sampling method.

Today, the company said it was working to provide the TGA with additional information as quickly as possible.

Anteotech share price snap shot

Despite a 15% fall this month, the AnteoTech share price has skyrocketed by 67% this year to date. It's also gained about 94% over the last 12 months.

In contrast, the benchmark S&P/ASX 200 Index (ASX: XJO) has returned 11% in the past year.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL share price leaping higher amid $1.9 billion funding news

ASX 200 investors are bidding up the CSL share price on Wednesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

Guess which ASX 200 healthcare share is jumping 7% on a guidance update

This healthcare share is performing better than expected in FY 2024.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

1 ASX healthcare stock that looks severely undervalued

I think this stock looks too cheap to miss.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Own Medibank shares? Here's why it's a rewarding day for you

Shareholders are getting a healthy boost today.

Read more »

Health professional looking at a laptop.
Healthcare Shares

Are CSL shares a must-buy in March?

Let's see what analysts are saying about this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

This ASX healthcare stock is up 72% on FDA news and 'historic moment'

Huge gains are been recorded by this stock on Tuesday. But why?

Read more »